Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

S. Ettou; E. Audureau; C. Humbrecht; B. Benet; H. Jammes; T. Clozel; V. Bardet; C. Lacombe; F. Dreyfus; P. Mayeux; E. Solary; M. Fontenay

doi:10.1038/leu.2012.152

Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

S. Ettou, E. Audureau, C. Humbrecht, B. Benet, H. Jammes, T. Clozel, V. Bardet, C. Lacombe, F. Dreyfus, P. Mayeux, E. Solary, M. Fontenay

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

24 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	2297-2299
Nombre de pages	3
journal	Leukemia
Volume	26
Numéro de publication	10
Les DOIs	https://doi.org/10.1038/leu.2012.152
état	Publié - 1 janv. 2012

Accès au document

10.1038/leu.2012.152

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{e733deed2fe34380953321194c4c17d3,

title = "Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML",

author = "S. Ettou and E. Audureau and C. Humbrecht and B. Benet and H. Jammes and T. Clozel and V. Bardet and C. Lacombe and F. Dreyfus and P. Mayeux and E. Solary and M. Fontenay",

note = "Funding Information: This work was supported by grants from the Direction r{\'e}gionale de la recherche clinique AP-HP (PHRC MAD-06). SE was recipient of a grant from the Canceropole Ile-de-France and from the Soci{\'e}t{\'e} Franc¸aise d{\textquoteright}H{\'e}matologie (SFH); CH and BB were recipients of a grant from Fondation pour la Recherche M{\'e}dicale. We are undebted to Professor B Quesnel, Lille; Professor O Beyne-Rauzy, Toulouse; Professor M Hunault-Berger Angers, Dr S Park, Paris Cochin; Dr B Slama, Avignon; for recording patients.",

year = "2012",

month = jan,

day = "1",

doi = "10.1038/leu.2012.152",

language = "English",

volume = "26",

pages = "2297--2299",

journal = "Leukemia",

issn = "0887-6924",

number = "10",

}

TY - JOUR

T1 - Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

AU - Ettou, S.

AU - Audureau, E.

AU - Humbrecht, C.

AU - Benet, B.

AU - Jammes, H.

AU - Clozel, T.

AU - Bardet, V.

AU - Lacombe, C.

AU - Dreyfus, F.

AU - Mayeux, P.

AU - Solary, E.

AU - Fontenay, M.

N1 - Funding Information: This work was supported by grants from the Direction régionale de la recherche clinique AP-HP (PHRC MAD-06). SE was recipient of a grant from the Canceropole Ile-de-France and from the Société Franc¸aise d’Hématologie (SFH); CH and BB were recipients of a grant from Fondation pour la Recherche Médicale. We are undebted to Professor B Quesnel, Lille; Professor O Beyne-Rauzy, Toulouse; Professor M Hunault-Berger Angers, Dr S Park, Paris Cochin; Dr B Slama, Avignon; for recording patients.

PY - 2012/1/1

Y1 - 2012/1/1

UR - http://www.scopus.com/inward/record.url?scp=84867403767&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.152

DO - 10.1038/leu.2012.152

M3 - Letter

C2 - 22743624

AN - SCOPUS:84867403767

SN - 0887-6924

VL - 26

SP - 2297

EP - 2299

JO - Leukemia

JF - Leukemia

IS - 10

ER -